These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12616334)

  • 81. [Origin, development, and modern application value of Chinese herbal lozenges].
    Wang Y; Xian JC; Chen SB; Chen W; Feng Y; Wang YJ
    Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(3):588-595. PubMed ID: 36872221
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Corrigendum to "Influence of electronic cigarette liquid flavors and nicotine concentration on subjective measures of abuse liability in young adult cigarette smokers" [Drug Alcohol Depend. 203 (2019) 27-34].
    Cobb CO; Lopez AA; Soule EK; Yen MS; Rumsey H; Scholtes RL; Rudy AK; Lipato T; Guy M; Eissenberg T
    Drug Alcohol Depend; 2021 May; 222():108645. PubMed ID: 33780790
    [No Abstract]   [Full Text] [Related]  

  • 83. Use of a lozenge to curb smoking appeal.
    GOULD WL
    GP; 1953 Feb; 7(2):53-4. PubMed ID: 13021305
    [No Abstract]   [Full Text] [Related]  

  • 84. Blood glucose levels produced by glucose tablets in abstaining smokers.
    Foulds J; Parth JD; Bover-Manderski MT
    Psychopharmacology (Berl); 2010 Apr; 209(3):283-4. PubMed ID: 20195574
    [No Abstract]   [Full Text] [Related]  

  • 85. [Measures directed against snuffing. Smoking is still "the worst bad guy"].
    Gilljam H; Boëthius G
    Lakartidningen; 2014 Feb 19-25; 111(8):317. PubMed ID: 24669450
    [No Abstract]   [Full Text] [Related]  

  • 86. New recreational nicotine lozenges, tablets, gummies and gum proliferate on the US market.
    Borowiecki M; Emery SL; Kostygina G
    Tob Control; 2024 Apr; 33(3):414-416. PubMed ID: 36319083
    [No Abstract]   [Full Text] [Related]  

  • 87. Phenogenetics of the Lozenge Loci in Drosophila Melanogaster. II. Genetics of Lozenge-Krivshenko. (Lz).
    Green MM
    Genetics; 1961 Sep; 46(9):1169-76. PubMed ID: 17248061
    [No Abstract]   [Full Text] [Related]  

  • 88. Abuse Liability of Baclofen.
    Praharaj SK
    Clin Psychopharmacol Neurosci; 2018 Feb; 16(1):126-127. PubMed ID: 29397677
    [No Abstract]   [Full Text] [Related]  

  • 89. Liability of Tobacco Manufacturers for Cancer.
    Br Med J; 1963 Jul; 2(5348):62. PubMed ID: 20789891
    [No Abstract]   [Full Text] [Related]  

  • 90. Liability for animals.
    KENNEY FB
    Vet Med; 1948 Jul; 43(27):337-9. PubMed ID: 18873117
    [No Abstract]   [Full Text] [Related]  

  • 91. Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
    Liu J; Wang J; Vansickel A; Edmiston J; Graff D; Sarkar M
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):241-250. PubMed ID: 33502815
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nicotine flux: a potentially important tool for regulating electronic cigarettes.
    Eissenberg T; Shihadeh A
    Nicotine Tob Res; 2015 Feb; 17(2):165-7. PubMed ID: 25332456
    [No Abstract]   [Full Text] [Related]  

  • 93. Nicotine vaccines to treat tobacco dependence.
    Goniewicz ML; Delijewski M
    Hum Vaccin Immunother; 2013 Jan; 9(1):13-25. PubMed ID: 23108361
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Guidelines for smoking cessation - update 2010].
    Lichtenschopf A;
    Wien Klin Wochenschr; 2011 May; 123(9-10):299-315. PubMed ID: 21590322
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Electronic nicotine delivery systems: a research agenda.
    Etter JF; Bullen C; Flouris AD; Laugesen M; Eissenberg T
    Tob Control; 2011 May; 20(3):243-8. PubMed ID: 21415064
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.
    Henningfield JE; Hatsukami DK; Zeller M; Peters E
    Drug Alcohol Depend; 2011 Jul; 116(1-3):1-7. PubMed ID: 21376479
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Nicotine addiction.
    Benowitz NL
    N Engl J Med; 2010 Jun; 362(24):2295-303. PubMed ID: 20554984
    [No Abstract]   [Full Text] [Related]  

  • 98. Abuse liability assessment of tobacco products including potential reduced exposure products.
    Carter LP; Stitzer ML; Henningfield JE; O'Connor RJ; Cummings KM; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3241-62. PubMed ID: 19959676
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Subjective responses to intravenous nicotine: greater sensitivity in women than in men.
    Sofuoglu M; Mooney M
    Exp Clin Psychopharmacol; 2009 Apr; 17(2):63-9. PubMed ID: 19331482
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Knowledge synthesis of smoking cessation among employed and unemployed young adults.
    Bader P; Travis HE; Skinner HA
    Am J Public Health; 2007 Aug; 97(8):1434-43. PubMed ID: 17600254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.